These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 14221628)
41. [The effect of pre-existing immunity induced by one of the antigens of live associated vaccine against plague, tularemia and brucellosis on the effectiveness of vaccination by others of their components. 3. Indices of immunologic reconstruction in guinea pigs immunized with plague EB vaccine and again with complex vaccine against plague, tularemia and brucellosis]. Pilinenko VG Zh Mikrobiol Epidemiol Immunobiol; 1967 Feb; 44(2):41-6. PubMed ID: 5614283 [No Abstract] [Full Text] [Related]
42. [Experimental effectiveness of combined vaccination against virus encephalitis, tularemia and brucellosis. I. Study of combined vaccination against virus encephalitis, tularemia and brucellosis in rabbits]. RYSHOV NV Zh Mikrobiol Epidemiol Immunobiol; 1962 Dec; 33():120-2. PubMed ID: 13983282 [No Abstract] [Full Text] [Related]
44. Newly attenuated Mycobacterium bovis mutants as vaccines against bovine tuberculosis, particularly for possums. Collins DM; Buddle BM; Kawakami RP; Hotter G; Mildenhall N; Mouat P; Murney R; Ataera H; Price-Carter M; Bruere P; Wards BJ; de Lisle GW Vet Microbiol; 2011 Jul; 151(1-2):99-103. PubMed ID: 21420259 [TBL] [Abstract][Full Text] [Related]
45. HOST-AGENT INTERACTION IN EXPERIMENTAL TUBERCULOSIS IN GUINEA PIGS, WITH SPECIAL REFERENCE TO THE EFFECTS OF BCG VACCINATION. BJERKEDAL T Am J Hyg; 1964 Jan; 79():86-106. PubMed ID: 14114358 [No Abstract] [Full Text] [Related]
46. [SEROLOGICAL EXAMINATION IN PLAGUE. VIII. ON THE PROBLEM OF THE SENSITIVITY AND SPECIFICITY OF THE ANTIBODY NEUTRALIZATION TESTS IN PLAGUE AND TULAREMIA]. LEVI MI; SAGATOVSKAIA LA; SUCHKOV IuG; MOMOT AG Zh Mikrobiol Epidemiol Immunobiol; 1963 May; 40():65-8. PubMed ID: 14077146 [No Abstract] [Full Text] [Related]
47. [Experimental study on the possibility of using live tularemia vaccine to increase resistance to heterologous infection disease]. Iliukhin VI; Plekhanova NG; Senina TV; Stanovaia OV; Kislichkin NN Zh Mikrobiol Epidemiol Immunobiol; 2004; (2):38-42. PubMed ID: 15188557 [TBL] [Abstract][Full Text] [Related]
48. Protection by killed vole bacillus vaccine against experimental tuberculosis in guinea pigs. PATERSON JC; CROMBIE DW; COLES JC Can J Res E Med Sci; 1949 Feb; 27(1):37-42. PubMed ID: 18124252 [No Abstract] [Full Text] [Related]
49. THE INFLUENCE OF PHASE ON THE PROTECTIVE POTENCY OF Q FEVER VACCINE. ORMSBEE RA; BELL EJ; LACKMAN DB; TALLENT G J Immunol; 1964 Mar; 92():404-12. PubMed ID: 14128986 [No Abstract] [Full Text] [Related]
50. [DYNAMICS OF SEROLOGICAL INDICES OF IMMUNITY IN ANIMALS IMMUNIZED WITH VACCINES AGAINST TICK-BORNE ENCEPHALITIS]. LVOV DK; ZAKLINSKAIA VA; FOKINA KV Vopr Virusol; 1963; 29():420-7. PubMed ID: 14071278 [No Abstract] [Full Text] [Related]
51. [The effect of pre-existing immunity against tularemia and brucellosis on the efficacy of vaccination with plague EB vaccine administered primarily in a combined plague, tularemia and brucellosis vaccine]. Pilipenko VG Zh Mikrobiol Epidemiol Immunobiol; 1968 Feb; 45(2):101-5. PubMed ID: 5650712 [No Abstract] [Full Text] [Related]
52. [THE EFFECT OF CORTICOSTEROID HORMONES AND ACTH ON THE COURSE OF VACCINAL PROCESSES IN TUBERCULOSIS]. KAPITANOV EA Zdravookhr Beloruss; 1963 Oct; 9():12-5. PubMed ID: 14141378 [No Abstract] [Full Text] [Related]
53. [Simultaneous vaccination of human subjects against brucellosis and tularemia. I]. AMANZHULOV RS; REMENTSOVA MM Zh Mikrobiol Epidemiol Immunobiol; 1958 Feb; 29(2):11-6. PubMed ID: 13570389 [No Abstract] [Full Text] [Related]
54. [COMPARATIVE STUDY OF NECROSIES IN TUBERCULOUS GUINEA PIGS AND TUBERCULOUS GUINEA PIGS PREVIOUSLY VACCINATED WITH ORAL BCG]. SOERENSEN B; AMARALJP DO Hospital (Rio J); 1964 Feb; 65():287-92. PubMed ID: 14140958 [No Abstract] [Full Text] [Related]
55. Vaccination against tuberculosis with nonliving vaccines. 3. Vaccination of guinea pigs with fractions of phenol-killed tubercle bacilli. WEISS DW; WELLS AQ Am Rev Respir Dis; 1960 Sep; 82():339-57. PubMed ID: 13784058 [No Abstract] [Full Text] [Related]
56. THE USE OF DIFFUSION CHAMBERS IN INVESTIGATING THE CELLULAR NATURE OF IMMUNITY IN EXPERIMENTAL TYPHOID AND TUBERCULOSIS. AKIYAMA T; MAEDA K; ASABA G; NAGATOMI H; WATABIKI S; USHIBA D Jpn J Microbiol; 1964 Jun; 8():37-48. PubMed ID: 14191492 [No Abstract] [Full Text] [Related]
58. [ON THE SIGNIFICANCE OF SPECIFIC ALLERGY FOR THE DEVELOPMENT OF EXPERIMENTAL VACCINATION TUBERCULOSIS OF THE GUINEA PIG AND POSSIBILITIES OF ITS CONTROL]. SCHWABE HK Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1963 Aug; 127():410-38. PubMed ID: 14042692 [No Abstract] [Full Text] [Related]
59. Vaccination against tuberculosis with nonliving vaccines. II. Vaccination of guinea pigs with phenol-killed tubercle bacilli. WEISS DW; WELLS AQ Am Rev Respir Dis; 1960 Apr; 81():518-37. PubMed ID: 13843704 [No Abstract] [Full Text] [Related]
60. [FEATURES OF IMMUNITY IN GUINEA PIGS IRRADIATED AFTER VACCINATION WITH SORBED TETANUS TOXOID]. ILLIUTOVICH AIu; RAIKIS BN; LABETSKII II Zh Mikrobiol Epidemiol Immunobiol; 1964 Nov; 41():99-103. PubMed ID: 14320188 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]